Clinical Trials

Phase NA Active not recruiting

24 enrolled

Carcinoma, Medullary

NCT02293954 2025-11-14

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

20 enrolled 8 charts

BreastGastrointestinalThoracic

Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Carcinoma, Medullary

NCT04759911 2025-11-13

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

Phase 2 Active not recruiting

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT07142005 2025-10-22

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

Not yet recruiting

40 enrolled

Carcinoma, Medullary

NCT06814496 2025-10-09

RABBIT

Phase 1/2 Recruiting

CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

NCT07138716 2025-08-24

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

Phase NA Recruiting

Carcinoma, Medullary

NCT07118176 2025-08-12

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Phase 1 Recruiting

BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETSarcomaThoracic

Adrenal Gland Neoplasms, Anus Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Colorectal Neoplasms, Carcinoma, Medullary, Cholangiocarcinoma, Neuroendocrine Tumors, Solitary Fibrous Tumors

NCT04877613 2025-07-03

GFRα4 CAR T Cells in MTC Patients

Phase 1 Active not recruiting

18 enrolled

Carcinoma, Medullary

NCT07048964 2025-07-03

A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations

Not yet recruiting

40 enrolled

Carcinoma, Medullary

NCT05534594 2025-06-24

MIMETIC

8 enrolled

CNSDermatologicEndocrineNETThoracic

Thyroid cancer, medullary, Thyroid Neoplasms, Carcinoma, Medullary

NCT03583528 2025-06-13

DOTATOC PET/CT for Imaging NET Patients

Active not recruiting

800 enrolled

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT04522570 2025-04-30

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Phase NA Active not recruiting

84 enrolled

Head & Neck

Lymphatic Metastasis, Thyroid Neoplasms, Carcinoma, Medullary

NCT02088645 2025-02-24

Lumed

Phase 1 Active not recruiting

24 enrolled

EndocrineHead & NeckNET

Thyroid cancer, medullary, Carcinoma, Medullary, Neuroendocrine Tumors

NCT06292988 2025-01-03

MYELO

DermatologicEndocrineGenitourinaryThoracic

500 enrolled

Carcinoma, Medullary

NCT04970134 2024-09-19

MOLTHY

Active not recruiting

150 enrolled

Carcinoma, Medullary

NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

96 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

NCT06523582 2024-07-26

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Recruiting

750 enrolled

CNSEndocrineGastrointestinalHead & NeckNETSarcoma

Carney-Stratakis Syndrome, Carney Triad, Pituitary Adenoma, Familial Isolated, Colorectal Neoplasms, Hereditary Nonpolyposis, Hamartoma Syndrome, Multiple, von Hippel-Lindau Disease, Adenoma, Islet Cell, Neurofibromatosis 1, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Tuberous Sclerosis, Li-Fraumeni Syndrome, Carcinoma, Medullary, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Gastrointestinal Stromal Tumors, Hyperparathyroidism, Primary, Carney Complex

NCT06520319 2024-07-25

Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma

Phase 1 Recruiting

20 enrolled

Carcinoma, Medullary

NCT02592356 2024-03-05

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

23 enrolled

CNSEndocrine

Paraganglioma, Extra-Adrenal, Carcinoma, Medullary

NCT06277180 2024-02-26

68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC

Phase NA Recruiting

50 enrolled

Carcinoma, Medullary

NCT06243965 2024-02-06

DSR-MTC

Phase 2 Not yet recruiting

246 enrolled

Fibrosis, Lymphatic Metastasis, Carcinoma, Medullary, Brain Stem Neoplasms

NCT06121271 2023-12-07

Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications

110 enrolled

Carcinoma, Medullary

NCT06067594 2023-10-06

Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma.

155 enrolled

Goiter, Nodular, Carcinoma, Medullary

NCT04031339 2023-05-10

ITCO

15,000 enrolled

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT05278364 2023-04-12

Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor

Phase 1/2 Unknown

184 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Medullary

NCT05796960 2023-04-04

ATCEU

3,917 enrolled

GastrointestinalHead & Neck

Thyroid cancer, follicular, Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT02363647 2022-08-31

Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

Phase NA Terminated

10 enrolled

Colonic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Carcinoma, Medullary

NCT01730638 2022-07-26

iTEP-CMT

Phase 1/2 Completed

25 enrolled

Head & Neck

Thyroid Diseases, Carcinoma, Medullary

NCT03647657 2022-02-10

177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Phase EARLY_PHASE1 Completed

8 enrolled

Thyroid cancer, medullary, Carcinoma, Medullary

NCT03838692 2021-10-13

Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer

Phase 2 Withdrawn

Carcinoma, Medullary

NCT03630120 2021-07-14

Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer

Phase 2 Terminated

6 enrolled 9 charts

Thyroid cancer, medullary, Thyroid Cancer, Papillary, Thyroid Diseases, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary

NCT04760171 2021-02-18

Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal Amyloidosis

10 enrolled

Alzheimer Disease, Dementia, Carcinoma, Medullary

NCT03643055 2020-11-04

18F-Fluorocholine PET/CT in Medullary Thyroid Cancer

80 enrolled

Carcinoma, Medullary

NCT04106843 2020-09-07

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

Phase 2 Withdrawn

CNSEndocrineHead & Neck

Paraganglioma, Parathyroid Neoplasms, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Medullary

NCT02174679 2020-07-27

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

No longer available

EndocrineNET

Carcinoma, Medullary, Neuroendocrine Tumors

NCT03246659 2020-03-20

GRAN-T-MTC

Phase 1 Completed

16 enrolled

Carcinoma, Medullary

NCT00582712 2019-12-09

An Initial Study of Lithium in Patients With Medullary Thyroid Cancer

Phase 2 Terminated

5 enrolled 7 charts

Carcinoma, Medullary

NCT03774862 2018-12-13

Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study

13 enrolled

Gastrointestinal

Colorectal Neoplasms, Carcinoma, Medullary, Microsatellite Instability

NCT00100828 2018-12-06

Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer

Phase 2 Terminated

6 enrolled 4 charts

Head & Neck

Head and Neck Neoplasms, Thyroid Neoplasms, Carcinoma, Medullary

NCT03636945 2018-08-17

TEPCMT

Phase NA Unknown

62 enrolled

Carcinoma, Medullary

NCT00416949 2018-07-18

Iodine I 131 in Treating Patients With Thyroid Cancer

Phase NA Terminated

9 enrolled 4 charts

DermatologicEndocrineGastrointestinalNET

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT02831179 2017-09-28

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Phase 1 Withdrawn

Non functioning pancreatic endocrine tumor, Adrenal Cortex Neoplasms, Carcinoid Tumor, Vipoma, Glucagonoma, Insulinoma, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Carcinoma, Merkel Cell, Carcinoma, Medullary, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Multiple Endocrine Neoplasia Type 2b

NCT00026533 2017-06-06

Thalidomide in Treating Patients With Thyroid Cancer

Phase 2 Completed

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary

NCT01927887 2017-06-06

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

12 enrolled 6 charts

Thyroid Cancer, Papillary, Carcinoma, Medullary

NCT00095836 2017-05-31

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

Phase 2 Completed

27 enrolled 16 charts

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT00519896 2017-04-25

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

Phase 2 Completed

35 enrolled 8 charts